How High Will OCGN Go Up?

How high will OCGN go up? Ocugen Inc (NASDAQ:OCGN)

The 3 analysts offering 12-month price forecasts for Ocugen Inc have a median target of 10.00, with a high estimate of 15.00 and a low estimate of 6.00. The median estimate represents a +75.75% increase from the last price of 5.69.

What is the target price for OCGN?

Stock Price Targets

High $15.00
Median $10.00
Low $6.00
Average $10.33
Current Price $6.03

Who is invested in OCGN?

Top 10 Owners of Ocugen Inc

Stockholder Stake Shares bought / sold
BlackRock Fund Advisors 5.62% +30,980
The Vanguard Group, Inc. 5.19% +484,702
Geode Capital Management LLC 1.69% +173,982
Northern Trust Investments, Inc.( 0.93% -61,710

Is OCGN good stock to buy?

The stock is at the lower part of a very wide and horizontal trend in the short term, and normally this may pose a good buying opportunity, though a breakdown through the bottom trend line at $5.39 will give a strong sell signal and a trend shift may be expected.

Why did OCGN stock drop?

Shares of Ocugen (NASDAQ:OCGN) are giving up ground in Wednesday's trading. The World Health Organization (WHO) granted Emergency Use Listing (EUL) for Bharat Biotech and Ocugen's Covaxin COVID-19 vaccine today -- a development that had been viewed as a potentially major bullish catalyst for Ocugen stock.


Related investments for How High Will OCGN Go Up?


What is BNGO target price?

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Bionano Genomics Inc have a median target of 12.00, with a high estimate of 14.00 and a low estimate of 10.00. The median estimate represents a +221.29% increase from the last price of 3.74.


Is Vanguard invested in OCGN?

This represents 5.6 percent ownership of the company.


How many shares are there of OCGN?

Share Statistics

Avg Vol (3 month) 3 31.81M
Shares Outstanding 5 199.19M
Implied Shares Outstanding 6 N/A
Float 8 195.22M
% Held by Insiders 1 2.42%

How many OCGN shares does BlackRock own?

2021-11-09 - BlackRock Inc. has filed a 13F-HR form disclosing ownership of 12,905,686 shares of Ocugen Inc (US:OCGN) with total holdings valued at $92,662,000 USD as of 2021-09-30.


Is Novavax publicly traded?

During 2020, the company redirected its efforts to focus on development and approval of its vaccine for COVID-19.

Novavax.

Novavax research and development laboratories in Gaithersburg
Type Public
Traded as Nasdaq: NVAX Russell 2000 component FWB: NVV1
ISIN US6700024010
Industry Biotechnology

Where is BNGO located?

The company was founded by Han Cao in January 2003 and is headquartered in San Diego, CA.


Will BNGO get FDA approval?

The Food and Drug Administration has not yet approved the device for use as a medical diagnostic tool in the U.S. However, healthcare entities can still use it for research purposes. The lack of FDA approval has also not hindered sales of the Saphyr in other countries.


Is BNGO undervalued?

Bionano Genomics (NASDAQ:BNGO) stock, along with most other meme stocks, has been tumbling in recent weeks. But unlike most other meme names, Bionano has a highly disruptive product, and its shares are tremendously undervalued.


Who owns Ocugen Inc?

Largest shareholders include BlackRock Inc., State Street Corp, Vanguard Group Inc, XBI - SPDR(R) S&P(R) Biotech ETF, VTSMX - Vanguard Total Stock Market Index Fund Investor Shares, IWM - iShares Russell 2000 ETF, Geode Capital Management, Llc, VEXMX - Vanguard Extended Market Index Fund Investor Shares, Susquehanna


Who owns SSGA Funds Management Inc?


Is OCGN low float?

Ocugen currently has a public float of 194,520,000 shares.


What companies is BlackRock invested in?

Portfolio Holdings for BlackRock

Company (Ticker) Portfolio Weight Share Price
Johnson & Johnson (JNJ) 0.9 164.74
JPMorgan Chase & Co. (JPM) 0.9 155.54
Berkshire Hathaway Inc Del Cl B New (BRK.B) 0.8 277.92
Visa Com Cl A (V) 0.8 233.82

Is BlackRock publicly traded?

BlackRock Inc. 1 As a major publicly traded company with a market capitalization of about $106 billion, BlackRock provides investment and technology services to both institutional and retail clients around the world.


What are institutional holdings?

Institutional ownership refers to the ownership stake in a company that is held by large financial organizations, pension funds, or endowments. Institutions generally purchase large blocks of a company's outstanding shares and can exert considerable influence upon its management.


Is Bionano genomics?

Bionano Genome Mapping Systems

Bionano systems provide essential genomic information no other technology can provide to help advance greater understanding of genome biology. Proprietary NanoChannel technology in Bionano Chips linearize DNA for direct imaging of ultra-long molecules.


Who runs BNGO?

Victory Capital Management Inc.


Who is BNGO CEO?

Bionano Genomics


Does Ark hold BNGO?

More than three months of persistent stock promotion along the lines of “today is finally the day!” ARK Genomic Revolution ETF (NYSEARCA:ARKG) will show more than just mouthpiece interest, BNGO remains a goose egg for the fund through the end of the first quarter.


Is Bionano Genomics profitable?

Given that Bionano Genomics didn't make a profit in the last twelve months, we'll focus on revenue growth to form a quick view of its business development. Shareholders of unprofitable companies usually expect strong revenue growth.


Was this post helpful?

Leave a Reply

Your email address will not be published.